Use of the Social Behaviour Assessment Schedule (SBAS) in a trial of maintenance antipsychotic therapy in schizophrenic outpatients: Pimozide versus fluphenazine

Social Psychiatry

Volumn 18, Issue 4, 1983, Pages 193-199

  Barnes, T R E ^a   Milavic, G ^a   Curson, D A ^a   Platt, S D ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DRUG DERIVATIVE; FLUPHENAZINE; FLUPHENAZINE DEPOT; PIMOZIDE; FLUPHENAZINE DECANOATE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; MALE; OUTPATIENT; SCHIZOPHRENIA; SOCIAL BEHAVIOR; CENTRAL NERVOUS SYSTEM; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG COMPARISON; DRUG THERAPY; PSYCHOSIS; THERAPY;

ADULT; CLINICAL TRIALS; FEMALE; FLUPHENAZINE; HUMAN; MALE; MIDDLE AGE; OUTPATIENTS; PIMOZIDE; SCHIZOPHRENIA; SOCIAL BEHAVIOR;

EID: 0020975192     PISSN: 00377813     EISSN: 14339285     Source Type: Journal    
DOI: 10.1007/BF00583530     Document Type: Article

References (28)

1. Evaluations of social functioning in a 3-year double-blind investigation of pimozide versus fluphenazine in chronic schizophrenia
2. Pimozide treatment of chronic schizophrenics as compared with haloperidol and penfluridol
3. Pimozide in the maintenance treatment of apathetic and emotionally withdrawn schizophrenics
4. Pimozide in the treatment of chronic schizophrenic patients
5. Important issues in the drug treatment of schizophrenia
6. Pimozide versus fluphenazine in ambulatory schizophrenics: a 12-month comparison study
7. A comparative controlled trial of pimozide and fluphenazine decanoate in the continuation therapy of schizophrenia
8. The social outcome of patients in a trial of long-term continuation therapy in schizophrenia: pimozide vs. fluphenazine
9. Outpatient maintenance of chronic schizophrenic patients with long-acting fluphenazine: a double-blind placebo trial
10. Fluphenazine and social therapy in the aftercare of schizophrenic patients
11. Practical considerations in the use of depot neuroleptics for the treatment of schizophrenia
12. Depressive and extrapyramidal symptoms and clinical effects: a trial of fluphenazine versus flupenthixol in maintenance of schizophrenic outpatients
13. A double-blind comparison of pimozide and chlorpromazine in the maintenance care of chronic schizophrenic outpatients
14. Pimozide and the social behaviour of schizophrenics
15. Trial of maintenance therapy in schizophrenia
16. Pimozide: a review of its pharmacological properties and therapeutic uses in psychiatry
17. The Social Behaviour Assessment Schedule (SBAS): rationale, contents, scoring and reliability of a new interview schedule
18. Effects of brief hospitalisation on psychiatric patients' behaviour and social functioning
19. Long-acting oral vs. injectable antipsychotic drugs in schizophrenics
20. The effect of fluphenazine upon social and vocational functioning in remitted schizophrenics
21. Prevention of relapse in schizophrenia: an evaluation of fluphenazine decanoate
22. Explanatory and pragmatic attitudes in therapeutic trials
23. Medico-social evaluation of the long-term pharmacotherapy of schizophrenia
24. The role of fluphenazine in lessening the burden of chronic schizophrenics in the community
25. Pimozide as a replacement for maintenance therapy in chronic schizophrenia
26. Symptomatology and social adjustment of psychiatric patients before and after hospitalisation